Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
<p style="text-align:justify;"> <b>Background:</b> Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA). <br...
Autors principals: | Bruyère, O, Burlet, N, Delmas, P, Rizzoli, R, Cooper, C, Reginster, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
BioMed Central
2008
|
Ítems similars
-
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
per: Rizzoli René, et al.
Publicat: (2008-12-01) -
SYMPTOMATIC SLOW ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS
per: L. I. Alekseeva
Publicat: (2012-04-01) -
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
per: E. V. Zonova
Publicat: (2021-04-01) -
The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: Accent on microcirculation parameters
per: A. S. Trofimova, et al.
Publicat: (2024-03-01) -
Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
per: V. I. Mazurov, et al.
Publicat: (2023-10-01)